124
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?

Pages 1114-1115 | Received 21 Oct 2018, Accepted 24 Oct 2018, Published online: 11 Jan 2019

References

  • Husnain M, Mackrides N, Vega F, et al. CD4+/CD8+ immunophenotype switching as a marker for intraocular and CNS involvement in mycosis fungoides. Leuk Lymphoma. 2018. https://doi.org/10.1080/10428194.2018.1526376
  • Herrmann JL, Hughey LC. Recognizing large-cell transformation of mycosis fungoides. J Am Acad Dermatol. 2012;67:665–672.
  • Benner MF, Jansen PM, Vermeer MH, et al. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 2012;119:1643–1649.
  • Overgaard NH, Jung JW, Steptoe RJ, et al. CD4+/CD8+ double-positive T cells: more than just a developmental stage?. J Leukoc Biol. 2015;97:31–38.
  • Bagot M, Echchakir H, Mami-Chouaib F, et al. Isolation of tumor-specific cytotoxic CD4+ and CD4 + CD8dim + T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood. 1998; 91:4331–4343.
  • Wilcox RA, Wada DA, Ziesmer SC, et al. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood. 2009;114:2936–2944.
  • Rübben A, Kempf W, Kadin ME, et al. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol. 2004;13:472–483.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.